Octant is engineering a new generation of drug discovery.

Octant is developing a multiplexed technology that uses synthetic biology, genome engineering, next-generation sequencing, and computational tools to simultaneously measure the activity of thousands of receptor pathways in human cells, paving the way for a new modality for drug discovery.

• Industry

  • Biotechnology

• Milestones

  • Lux investment: 2017

• Founders

  • Sri Kosuri
  • Ramsey Homsany

  LUX Partners

  • Adam Goulburn

• Latest Tweets

  • Check out this blogpost by @MollyGasp and @winnieLLiu! They share how @OctantBio multiplexed tech accelerates the… https://t.co/DbH1AIMIy8@OctantBio - 08:23 PM Jan 12th
  • 2021 - let's go. Octant is #HIRINGNOW for multiple positions. Join our team! https://t.co/tzAjz0vbrC. .… https://t.co/agWqTUeijR@OctantBio - 06:45 PM Jan 7th
  • Happy new year! If you’re interested in the Fall 2021 SBA program, please submit your application by Friday. See… https://t.co/6TN4Wo0khh@OctantBio - 05:14 PM Jan 4th